Twist Bioscience Corp (NAS:TWST)
$ 42.23 0.87 (2.1%) Market Cap: 2.46 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 4.38 GF Score: 83/100

Twist Bioscience Corp at Cowen Health Care Conference (Virtual) - Fireside Chat Transcript

Mar 07, 2022 / 07:10PM GMT
Release Date Price: $47.67 (-1.00%)
Steve Mah
Cowen and Company, LLC - Analyst

All right. Good afternoon, everyone. I'm Steve Mah, the newest member of Cowen's tools and diagnostics research team joining Dan Brennan and Max Masucci. (Conference Instructions)

So it's our pleasure to welcome Emily Leproust and Jim Thorburn from Twist Bioscience to our conference. I think most people know Twist. So I think we'll forego the company introduction and just jump right into the fireside chat session. So today, we're going to focus on outlook for 2022, progress across the base business, pipeline development, and maybe some of your philosophy on some of your business decisions and how you see Twist evolving over the next three to five years.

Emily Leproust
Twist Bioscience Corporation - CEO & Co-Founder

Thanks for having us.

Questions & Answers

Steve Mah
Cowen and Company, LLC - Analyst

Okay. All right. So yeah, so first question, maybe we'll start from a high level first and then drill down later. But as I've known Twist for a long

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot